The tumor exhibited a tumor mutational burden of 7.4 mutations per megabase, was negative for programmed death-ligand 1 (PD-L1) expression (<1%), and microsatellite instability (MSI) could not be assessed due to insufficient tumor content (<30%). This evidence concerns the gene CD274 and neoplasm.